CTMX
Price
$0.54
Change
-$0.07 (-11.48%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
48.76M
34 days until earnings call
PYXS
Price
$0.94
Change
-$0.08 (-7.84%)
Updated
Apr 3, 02:56 PM (EDT)
Capitalization
62.82M
36 days until earnings call
Ad is loading...

CTMX vs PYXS

Header iconCTMX vs PYXS Comparison
Open Charts CTMX vs PYXSBanner chart's image
CytomX Therapeutics
Price$0.54
Change-$0.07 (-11.48%)
Volume$1.1K
Capitalization48.76M
Pyxis Oncology
Price$0.94
Change-$0.08 (-7.84%)
Volume$200
Capitalization62.82M
CTMX vs PYXS Comparison Chart
Loading...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTMX vs. PYXS commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTMX is a Buy and PYXS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (CTMX: $0.61 vs. PYXS: $1.02)
Brand notoriety: CTMX and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTMX: 45% vs. PYXS: 86%
Market capitalization -- CTMX: $48.76M vs. PYXS: $62.82M
CTMX [@Biotechnology] is valued at $48.76M. PYXS’s [@Biotechnology] market capitalization is $62.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTMX’s FA Score shows that 0 FA rating(s) are green whilePYXS’s FA Score has 1 green FA rating(s).

  • CTMX’s FA Score: 0 green, 5 red.
  • PYXS’s FA Score: 1 green, 4 red.
According to our system of comparison, PYXS is a better buy in the long-term than CTMX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTMX’s TA Score shows that 4 TA indicator(s) are bullish while PYXS’s TA Score has 4 bullish TA indicator(s).

  • CTMX’s TA Score: 4 bullish, 3 bearish.
  • PYXS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CTMX is a better buy in the short-term than PYXS.

Price Growth

CTMX (@Biotechnology) experienced а +2.46% price change this week, while PYXS (@Biotechnology) price change was -2.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

CTMX is expected to report earnings on May 07, 2025.

PYXS is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PYXS($62.8M) has a higher market cap than CTMX($48.8M). PYXS YTD gains are higher at: -34.615 vs. CTMX (-40.903). CTMX has higher annual earnings (EBITDA): 26.8M vs. PYXS (-64.04M). PYXS has more cash in the bank: 145M vs. CTMX (101M). CTMX has less debt than PYXS: CTMX (9.39M) vs PYXS (20.5M). CTMX has higher revenues than PYXS: CTMX (138M) vs PYXS (16.1M).
CTMXPYXSCTMX / PYXS
Capitalization48.8M62.8M78%
EBITDA26.8M-64.04M-42%
Gain YTD-40.903-34.615118%
P/E Ratio1.60N/A-
Revenue138M16.1M857%
Total Cash101M145M70%
Total Debt9.39M20.5M46%
FUNDAMENTALS RATINGS
CTMX: Fundamental Ratings
CTMX
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTMXPYXS
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 14 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
88%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MS119.273.53
+3.05%
Morgan Stanley
WSBC31.050.40
+1.31%
WesBanco
WFG78.770.74
+0.95%
West Fraser Timber Co Ltd
ACET0.72-0.01
-1.50%
Adicet Bio
ZH4.15-0.16
-3.71%
Zhihu

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with KURA. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
+11.48%
KURA - PYXS
64%
Loosely correlated
+2.19%
CTMX - PYXS
39%
Loosely correlated
+4.95%
ABOS - PYXS
39%
Loosely correlated
+0.47%
BLRX - PYXS
39%
Loosely correlated
+6.16%
RXRX - PYXS
35%
Loosely correlated
+3.83%
More